The Net Margin of Interpace Biosciences Inc (IDXG) is 14.28%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 14.28% |
| 2023-12-31 | 4.86% |
| 2022-12-31 | -69.18% |
| 2021-12-31 | -45.02% |
| 2020-12-31 | -81.79% |
| 2019-12-31 | -110.33% |
| 2018-12-31 | -57.99% |
| 2017-12-31 | -76.73% |
| 2016-12-31 | -63.36% |
| 2015-12-31 | -121.28% |